Cannabidiol (CBD) and Tetrahydrocannabinol (THC) are naturally occurring compounds
in various plant species belonging to the Cannabis genus. Due to their widespread presence and
diverse impact on the human body have been extensively researched and analyzed. Despite
sharing similar chemical structures, CBD and THC exhibit distinct psychoactive effects.
The principal psychoactive constituent in Cannabis is tetrahydrocannabinol (THC). The
compound induces a state of euphoria or heightened sensation in the user. The mechanism of
action involves the binding of the substance to the cannabinoid receptors located in the brain,
thereby imitating the effects of endogenous neurotransmitters. This results in the modulation of
various cognitive and behavioral processes, including but not limited to pleasure, memory,
cognition, attention, motor coordination, and temporal perception.
In contrast, cannabidiol (CBD) lacks psychoactive properties, thereby precluding the
manifestation of the euphoric effects commonly attributed to tetrahydrocannabinol (THC).
Furthermore, it engages with the cannabinoid receptors located in the brain; however, its impacts
are distinct. CBD is purported to have various therapeutic effects, such as pain management,
anxiety, and depression reduction, and mitigation of cancer and cancer treatment-related
symptoms, instead of inducing a sense of euphoria.
An increasing body of scholarly literature indicates that CBD has the potential to aid in
the management of symptoms related to diverse medical conditions. Anxiety is a prevalent
psychological disorder. As per a 2021 review published in the academic journal by Melas and
colleagues "Neurotherapeutics," preclinical research provides robust evidence in favor of CBD's
efficacy in treating a range of anxiety disorders, including generalized anxiety disorder, panic
disorder, social anxiety disorder, obsessiv
Order this paper